LARANJEIRA CHARLES ANTHONY 4
4 · Pacira BioSciences, Inc. · Filed Nov 24, 2021
Insider Transaction Report
Form 4
LARANJEIRA CHARLES ANTHONY
Chief Technical Officer
Transactions
- Exercise/Conversion
Common Stock
[F1]2021-11-22$44.10/sh+7,500$330,750→ 33,602 total - Exercise/Conversion
Stock Option (Right to Buy)
[F2]2021-11-22−7,500→ 0 totalExercise: $44.10Exp: 2027-06-02→ Common Stock (7,500 underlying)
Footnotes (2)
- [F1]Includes 421 shares of common stock acquired under the issuer's employee stock purchase plan in June 2021.
- [F2]The stock option vested and became exercisable as to 25% of the option shares on May 1, 2018, and vested as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remained in continuous service with the issuer as of each vesting date.
Signature
/s/ Kristen Williams, Attorney-in-Fact|2021-11-24